NCT04461587View on ClinicalTrials.gov

Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

November 10, 2022

Study Completion Date

November 16, 2022

Conditions

Coal Workers' Pneumoconiosis (Complicated)

Interventions

DRUG

Pirfenidone

see previous entries

Trial Locations (1)

24210

Pulmonary Research of Abingdon, LLC, Abingdon

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Pulmonary Research of Abingdon, LLC

OTHER